Hims & Hers Health Net Profit Margin 2020-2024 | HIMS

Current and historical net profit margin for Hims & Hers Health (HIMS) from 2020 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue. Hims & Hers Health net profit margin for the three months ending September 30, 2024 was .
Hims & Hers Health Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2024-09-30 $1.24B $0.10B 8.13%
2024-06-30 $1.07B $0.02B 1.59%
2024-03-31 $0.96B $-0.00B -0.31%
2023-12-31 $0.87B $-0.02B -2.75%
2023-09-30 $0.79B $-0.04B -4.54%
2023-06-30 $0.71B $-0.05B -6.61%
2023-03-31 $0.62B $-0.06B -9.72%
2022-12-31 $0.53B $-0.07B -12.52%
2022-09-30 $0.45B $-0.09B -19.33%
2022-06-30 $0.37B $-0.08B -22.19%
2022-03-31 $0.32B $-0.07B -22.43%
2021-12-31 $0.27B $-0.11B -39.34%
2021-09-30 $0.23B $-0.08B -35.53%
2021-06-30 $0.20B $-0.07B -36.41%
2021-03-31 $0.17B $-0.06B -37.06%
2020-12-31 $0.15B $-0.02B -12.16%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $5.141B $0.872B
Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco.
Stock Name Country Market Cap PE Ratio
Tempus AI (TEM) United States $8.497B 0.00
Inspire Medical Systems (INSP) United States $5.276B 164.53
Privia Health (PRVA) United States $2.533B 211.10
Enovis (ENOV) United States $2.529B 17.15
IRhythm Technologies (IRTC) United States $2.362B 0.00
Azenta (AZTA) United States $2.001B 99.78
Omnicell (OMCL) United States $1.964B 64.26
Clover Health Investments (CLOV) United States $1.644B 0.00
10x Genomics (TXG) United States $1.643B 0.00
Schrodinger (SDGR) United States $1.378B 0.00
Phreesia (PHR) United States $1.072B 0.00
Butterfly Network (BFLY) United States $0.650B 0.00
Standard BioTools (LAB) United States $0.562B 0.00
Talkspace (TALK) United States $0.522B 0.00
Fulgent Genetics (FLGT) United States $0.520B 0.00
Definitive Healthcare (DH) United States $0.483B 83.60
Health Catalyst (HCAT) United States $0.459B 0.00
TruBridge (TBRG) United States $0.244B 71.22
Pulmonx (LUNG) United States $0.237B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.214B 0.00
American Well (AMWL) United States $0.122B 0.00
EUDA Health Holdings (EUDA) Singapore $0.107B 0.00
P3 Health Partners (PIII) United States $0.075B 0.00
HeartBeam (BEAT) United States $0.067B 0.00
111 (YI) China $0.053B 0.00
CareCloud (CCLD) United States $0.046B 0.00
Zepp Health (ZEPP) China $0.040B 0.00
SHL Telemedicine (SHLT) Israel $0.040B 0.00
Outset Medical (OM) United States $0.039B 0.00
Movano (MOVE) United States $0.020B 0.00
Bullfrog AI Holdings (BFRG) United States $0.019B 0.00
Streamline Health Solutions (STRM) United States $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.012B 0.00
MSP Recovery (LIFW) United States $0.010B 0.00
Precipio (PRPO) United States $0.009B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Predictive Oncology (POAI) United States $0.004B 0.00
Syra Health (SYRA) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.002B 0.00
Zhongchao (ZCMD) China $0.002B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00